• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Levine Leichtman backs Prime Global

  • Alessia Argentieri
  • Alessia Argentieri
  • 27 April 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Levine Leichtman Capital Partners has invested in Prime Global Medical Communications.

The GP invested in the company in partnership with its management team, led by founder and CEO Graeme Peterson, who will continue to run the business.

This is the fifth investment made by the GP via Levine Leichtman Capital Partners Europe II, which closed on €463m in October 2020. The fund combines debt and equity investments, targeting various sectors, including business services, healthcare, education and engineering.

Prime Global Medical Communications

  • DEAL:

    Buyout

  • LOCATION:

    Knutsford

  • SECTOR:

    Media agencies

  • FOUNDED:

    1997

  • TURNOVER:

    £21.5m (2019)

  • STAFF:

    250

Prime Global appointed BDO to find a buyer in July 2020, according to Unquote sister publication Mergermarket. The process, which saw the business marketed based on EBITDA of €8m, attracted the interest of around 30 bidders, as reported by Mergermarket in February 2021.

Company
Founded in 1997, Prime Global is a medical communications company that provides biotech, pharmaceuticals and healthcare businesses with scientific and medical communications, consumer health, patient-integrated science, and market access.

The consultancy specialises in a range of therapy areas, such as oncology, cardiovascular disease, diabetes, metabolic disorders, the central nervous system, respiratory illness, infectious diseases, vaccines, virology, diagnostics, urology, nephrology, haematology, dermatology, gastrointestinal ailments, rare and genetic disorders, immuno-inflammation, and allergies.

Prime Global employs 250 staff across its offices in the UK (London, Knutsford, Macclesfield, Brighton, Oxford and Cambridge) and the US (New York and San Francisco). It also has teams in San Diego, Germany, and New Zealand.

The company reported EBIT of £3.1m and profit of £2.8m from revenue of £21.5m in 2019.

People
Prime Global Medical Communications – Graeme Peterson (founder, CEO).
Levine Leichtman Capital Partners – John O'Neill (head of Europe).

Advisers
Company – BDO (corporate finance); Addleshaw Goddard (legal).
Equity – Results Healthcare (corporate finance); PwC (financial due diligence); Goodwin Procter (legal); CIL (commercial due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • UK / Ireland
  • Media
  • PwC
  • BDO LLP
  • Addleshaw Goddard
  • Goodwin
  • United Kingdom

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013